Is MY4 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MY4 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MY4 (€23.06) is trading above our estimate of fair value (€20.82)
Significantly Below Fair Value: MY4 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MY4?
Key metric: As MY4 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
The above table shows the Price to Book ratio for MY4. This is calculated by dividing MY4's market cap by their current
book value.
What is MY4's PB Ratio?
PB Ratio
4.2x
Book
AU$17.54b
Market Cap
AU$73.08b
MY4 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: MY4 is expensive based on its Price-To-Book Ratio (4.2x) compared to the Global Industrial REITs industry average (0.9x).
Price to Book Ratio vs Fair Ratio
What is MY4's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
MY4 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
4.2x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate MY4's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst MY4 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€23.06
€23.42
+1.6%
10.7%
€26.16
€16.66
n/a
11
Nov ’25
€21.64
€22.67
+4.8%
12.8%
€25.81
€14.61
n/a
11
Oct ’25
€22.63
€22.38
-1.1%
12.8%
€25.27
€14.90
n/a
11
Sep ’25
€20.02
€20.60
+2.9%
17.7%
€24.20
€12.00
n/a
12
Aug ’25
€21.62
€20.06
-7.2%
17.3%
€24.14
€11.97
n/a
12
Jul ’25
€22.30
€20.26
-9.1%
17.5%
€24.79
€12.29
n/a
12
Jun ’25
€20.10
€19.37
-3.6%
15.9%
€23.22
€12.21
n/a
12
May ’25
€18.83
€18.00
-4.4%
15.6%
€21.45
€11.95
n/a
13
Apr ’25
€19.93
€17.89
-10.3%
15.4%
€21.07
€11.99
n/a
13
Mar ’25
€17.93
€17.67
-1.4%
14.3%
€20.69
€12.02
n/a
13
Feb ’25
€14.99
€15.49
+3.4%
8.7%
€17.17
€11.72
n/a
12
Jan ’25
€15.27
€15.10
-1.1%
9.4%
€17.36
€11.86
n/a
12
Dec ’24
€13.68
€14.55
+6.4%
12.3%
€17.13
€10.45
n/a
13
Nov ’24
€12.44
€14.26
+14.6%
11.4%
€16.74
€10.35
€21.64
13
Oct ’24
€12.82
€14.65
+14.3%
11.3%
€16.96
€10.49
€22.63
13
Sep ’24
€13.43
€14.07
+4.8%
11.8%
€16.78
€10.38
€20.02
14
Aug ’24
€12.26
€13.62
+11.1%
10.3%
€15.29
€10.65
€21.62
14
Jul ’24
€11.98
€13.69
+14.3%
9.3%
€15.00
€10.70
€22.30
14
Jun ’24
€11.78
€13.39
+13.7%
9.4%
€14.76
€10.54
€20.10
13
May ’24
€11.32
€13.69
+21.0%
7.2%
€14.78
€11.41
€18.83
12
Apr ’24
€11.30
€13.96
+23.5%
7.7%
€15.11
€11.66
€19.93
12
Mar ’24
€12.10
€13.96
+15.4%
8.2%
€15.27
€11.78
€17.93
13
Feb ’24
€12.86
€13.91
+8.2%
8.6%
€16.02
€11.72
€14.99
13
Jan ’24
€10.81
€13.84
+28.0%
9.5%
€15.95
€11.67
€15.27
14
Dec ’23
€12.27
€13.84
+12.7%
9.5%
€15.95
€11.67
€13.68
14
Nov ’23
€11.19
€15.47
+38.2%
8.9%
€17.33
€12.28
€12.44
14
Analyst Forecast: Target price is lower than the current share price.